Skip to main content

Animations

MJFF Publications

2781 - 2790 of 6564 Results
Title
Year
  • Year
  • 2024
  • 2025
  • 2026
  • 2026
  • 2024
  • 2026
  • 2023
  • 2024
  • 2022
  • 2024
  • Summary Details
    OPEN
    Title: Genetic Modifiers of LRRK2 Parkinson's Disease: A Replication Study in Arab‐Berbers
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29735
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Pregnenolone Reduces L‐Dopa‐Induced Dyskinesias in Female Parkinsonian Monkeys
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30280
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohort
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x261431204
    Citation Count: 0
  • Summary Details
    OPEN
    Title: DeepFaceMouse enables scalable prediction of large-scale brain activity from facial dynamics in mice
    Journal Name: Cell Reports Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.crmeth.2026.101480
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Bacteroides acidifaciens: Linking dietary fiber to liver health
    Journal Name: Cell Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cmet.2024.08.002
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Development of cannabinoid-based therapies for Parkinson’s disease: emphasis on targeting cannabinoid receptors as CB2, PPAR-γ and GPR55 receptors
    Journal Name: Molecular Neurodegeneration Advances
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s44477-025-00016-7
    Citation Count: 0
  • Summary Details
    OPEN
    Title: CSF alpha‐synuclein aggregates by seed amplification and clinical presentation of AD
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.13109
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Brain-first forms of Parkinson's disease are over-represented in patients with non-responsive resting tremor
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2024.106691
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function
    Journal Name: Biomedicine & Pharmacotherapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.biopha.2022.113896
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Tetrabenazine‐induced acute dystonic reaction during the treatment of comorbid tics in a young woman with autism spectrum disorder
    Journal Name: Psychiatry and Clinical Neurosciences
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/pcn.13705
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.